Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from SPRO

3 Pharma Stocks to Snatch up During Market Dips

The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more.

StockNews.com

3 Affordable Pharma Stocks to Buy for Portfolio Gains

The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that end, affordable pharma stocks ACADIA Pharmaceuticals (ACAD), Astellas Pharma (ALPMY), and Spero Therapeutics (SPRO), trading under $20, could be solid buys now. Read on….

StockNews.com

4 Sky-Rocketing Pharma Stocks to Watch

The pharmaceutical industry is experiencing significant growth due to the rising demand for quality healthcare and high-quality drugs. This surge is further supported by the rapid growth in the global elderly population and the increase in chronic illnesses. Therefore, investors could consider adding pharma stocks Spero Therapeutics (SPRO), Wave Life…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Top 4 Pharma Stocks on the Rise for Potential Gains

Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains.…

StockNews.com

3 Pharma Stocks to Buy Before Year-End

Amid rising global medical needs, the pharmaceutical industry is expected to witness robust growth in the coming years. Given the solid long-term prospects of the industry, fundamentally sound pharma stocks Spero Therapeutics (SPRO), Astellas Pharma (ALPMY) and Supernus Pharmaceuticals (SUPN) could be ideal buys for steady gains. Read on.

StockNews.com

3 Resilient Pharma Stocks to Buy This Week

Amid rising global medical needs and advancement in technology, the pharma industry is expected to witness robust growth in the coming years. Given this backdrop, resilient pharma stocks such as Spero Therapeutics (SPRO), GoodRx Holdings (GDRX) and Kamada (KMDA) might be solid buys now. Read on.

StockNews.com

3 Pharma Stocks Every Investor Should Know

The pharma sector is poised to witness significant growth due to the widespread adoption of generic medicines and emerging technologies. Therefore, fundamentally strong pharma stocks Pfizer (PFE), Sanofi (SNY), and Spero Therapeutics (SPRO) might be solid buys. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

FDA Identifies Review Issues For Spero's Tebipenem Application, Shares Plunge

Spero Therapeutics Inc (NASDAQ:SPRO) will defer current commercialization activities for tebipenem HBr based on feedback from a recent Late Cycle Meeting (LCM) with the FDA. The discussion suggested that the data package may be insufficient to support approval during this review cycle. In evaluating the efficacy of tebipenem HBr in Phase 3 (ADAPT-PO)…

Benzinga

People

Mangeet Kaur BounsMangeet

595 stories

Neha PanjwaniFrom

97 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

BristolMyers Squibb Company

the US Food and Drug Administration

ACADIA Pharmaceuticals Inc

15 stories

ALPMY

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.